Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Correlation Between Targeted Hemoglobin A1C Levels and Prevention of Recurrent Cardiovascular Events in Type 2 Diabetes After Coronary Intervention

NCT05134129 is registered in ClinicalTrials.gov with Shanghai 10th People's Hospital as lead sponsor.

NCT NCT05134129
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05134129 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Correlation Between Targeted Hemoglobin A1C Levels and Prevention of Recurrent Cardiovascular Events in Type 2 Diabetes After Coronary Intervention
Lead sponsor
Shanghai 10th People's Hospital
Phase
Observational
Overall status
Unknown status
Start date
April 25, 2021
Completion date
September 1, 2024
Enrollment
1,500 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes mellitus, percutaneous coronary intervention